Abstract: A blood substitute employs combinations of fluoro or perfluorochemicals capable in the presence of emulsifying agents of forming emulsions stable at room temperature and possessing enhanced oxygen carrying capacity; the invention enables preparation of an improved blood substitute, with improved O.sub.2 carrying capacity and stability, as well as lessened anaphylactoid reaction.
Type:
Grant
Filed:
August 23, 1993
Date of Patent:
July 18, 1995
Assignee:
International Therapeutics Inc.
Inventors:
Walter B. Dandliker, W. Keith R. Watson, Thomas C. Drees
Abstract: A blood substitute employs combinations of fluoro or perfluorochemicals capable in the presence of emulsifying agents of forming emulsions stable at room temperature and possessing enhanced oxygen carrying capacity; the invention enables preparation of an improved blood substitute, with improved O.sub.2 carrying capacity and stability, as well as lessened anaphylactoid reaction.
Type:
Grant
Filed:
February 17, 1989
Date of Patent:
September 7, 1993
Assignee:
International Therapeutics, Inc.
Inventors:
Walter B. Dandliker, W. Keith R. Watson, Thomas C. Drees
Abstract: A blood substitute employs combinations of fluoro or perfluorochemicals capable in the presence of emulsifying agents of forming emulsions stable at room temperature and possessing enhanced oxygen carrying capacity; the invention enables preparation of an improved blood substitute, with improved O.sub.2 carrying capacity and stability, as well as lessened anaphylactoid reaction.
Type:
Grant
Filed:
February 17, 1989
Date of Patent:
February 13, 1990
Assignee:
International Therapeutics Inc.
Inventors:
Walter B. Dandliker, W. Keith R. Watson, Thomas C. Drees